Due to a lack of regulation on pharmaceutical company marketing through social media outlets like Facebook and Twitter, drug companies are asking the FDA for clearer guidelines so that they may market their products without fear of reprisal. An Indianapolis race car driver, who is working directly with the Danish drug giant Novo Nordisk, has tweeted about his use of Nordisk's insulin pen for his Type I diabetes and it is unclear whether his plugging the Danish drug company's product is acceptable or not. Time will tell. Read more about Pharma social media marketing at Time Magazine's online site,
here.
